Skip to content

Clinical trials

Terminated Observational Lymphoma, Non-Hodgkin trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Observational Status: Terminated Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20084
20092
20102
20111
20171
20181
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vanderbilt-Ingram Cancer Center3
Stanford University2
Abramson Cancer Center at Penn Medicine1
Adaptive Biotechnologies1
Celgene1
City of Hope Medical Center1
Columbia University1
Juno Therapeutics, a Subsidiary of Celgene1
National Cancer Institute (NCI)1
National Institutes of Health Clinical Center (CC)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin19
Leukemia, Lymphocytic, Chronic, B-Cell12
Lymphoma, Follicular12
Hodgkin Disease11
Lymphoma, Large B-Cell, Diffuse11
Precursor Cell Lymphoblastic Leukemia-Lymphoma11
Leukemia, Myeloid, Acute10
Lymphoma, Mantle-Cell10
Multiple Myeloma10
Burkitt Lymphoma9

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.